A soluble receptor for advanced glycation end-products inhibits myocardial apoptosis induced by ischemia/reperfusion via the JAK2/STAT3 pathway

Apoptosis

Volumn 20, Issue 8, 2015, Pages 1033-1047

  Jiang, Xue ^a   Guo, Cai Xia ^a   Zeng, Xiang Jun ^b   Li, Hui Hua ^b   Chen, Bu Xing ^a   Du, Feng He ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cardiac function; Ischemia reperfusion; JAK2 STAT3; Myocardium; sRAGE

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ADVANCED GLYCATION END PRODUCT RECEPTOR; EVANS BLUE; JANUS KINASE 2; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; STAT3 PROTEIN; STAT5A PROTEIN; STAT6 PROTEIN; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ALPHA-CYANO-(3,4-DIHYDROXY)-N-BENZYLCINNAMIDE; APOPTOSIS REGULATORY PROTEIN; CHROMONE DERIVATIVE; FLAVONOID; JAK2 PROTEIN, MOUSE; JAK2 PROTEIN, RAT; MORPHOLINE DERIVATIVE; PEPTIDE FRAGMENT; PROTEIN KINASE INHIBITOR PEPTIDE (5-24); STAT3 PROTEIN, MOUSE; STAT3 PROTEIN, RAT; TYRPHOSTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART PROTECTION; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENE EXPRESSION; HEART MUSCLE; METABOLISM; SPRAGUE DAWLEY RAT;

MUS; RATTUS;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CHROMONES; FLAVONOIDS; GENE EXPRESSION; JANUS KINASE 2; MALE; MICE, INBRED C57BL; MORPHOLINES; MYOCARDIUM; MYOCYTES, CARDIAC; PEPTIDE FRAGMENTS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TYRPHOSTINS;

EID: 84933181943     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-015-1130-4     Document Type: Article

References (47)

1. 2+ exchanger in developing rats. Cell Physiol Biochem 34(2):313-324
2. Matsushima S, Tsutsui H, Sadoshima J (2014) Physiological and pathological functions of NADPH oxidases during myocardial ischemia-reperfusion. Trends Cardiovasc Med 24(5):202-205
3. Braunersreuther V, Montecucco F, Asrih M, Pelli G, Galan K, Frias M, Burger F, Quindere AL, Montessuit C, Krause KH, Mach F, Jaquet V (2013) Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury. J Mol Cell Cardiol 64:99-107
4. Cash JL, Bena S, Headland SE, McArthur S, Brancaleone V, Perretti M (2013) Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23. EMBO Rep 14(11):999-1007
5. Orogo AM, Gustafsson AB (2013) Cell death in the myocardium: my heart won't go on. IUBMB Life 65(8):651-656
6. Marongiu E, Crisafulli A (2014) Cardioprotection acquired through exercise: the role of ischemic preconditioning. Curr Cardiol Rev 10(4):336-348
7. Buchholz B, Donato M, D'Annunzio V, Gelpi RJ (2014) Ischemic postconditioning: mechanisms, comorbidities, and clinical application. Mol Cell Biochem 392(1-2):1-12
8. Schmidt MR, Pryds K, Botker HE (2014) Novel adjunctive treatments of myocardial infarction. World J Cardiol 6(6):434-443
9. Falcone C, Bozzini S, Guasti L, D'Angelo A, Capettini AC, Paganini EM, Falcone R, Moia R, Gazzaruso C, Pelissero G (2013) Soluble RAGE plasma levels in patients with coronary artery disease and peripheral artery disease. ScientificWorldJournal 2013:584504
10. Basta G (2008) Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis 196(1):9-21
11. Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, Reiss K, Saftig P, Bianchi ME (2008) A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 22(10):3716-3727
12. Xie J, Mendez JD, Mendez-Valenzuela V, Aguilar-Hernandez MM (2013) Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signal 25(11):2185-2197
13. Yan SF, Ramasamy R, Schmidt AM (2010) Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. Biochem Pharmacol 79(10):1379-1386
14. Maillard-Lefebvre H, Boulanger E, Daroux M, Gaxatte C, Hudson BI, Lambert M (2009) Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases. Rheumatology (Oxford) 48(10):1190-1196
15. Mahajan N, Malik N, Bahl A, Sharma Y, Dhawan V (2009) Correlation among soluble markers and severity of disease in non-diabetic subjects with pre-mature coronary artery disease. Mol Cell Biochem 330(1-2):201-209
16. Lu L, Zhang Q, Xu Y, Zhu ZB, Geng L, Wang LJ, Jin C, Chen QJ, Schmidt AM, Shen WF (2010) Intra-coronary administration of soluble receptor for advanced glycation end-products attenuates cardiac remodeling with decreased myocardial transforming growth factor-beta1 expression and fibrosis in minipigs with ischemia-reperfusion injury. Chin Med J (Engl) 123(5):594-598
17. Nakamura K, Adachi H, Matsui T, Kurita Y, Takeuchi M, Yamagishi S (2009) Independent determinants of soluble form of receptor for advanced glycation end products in elderly hypertensive patients. Metabolism 58(3):421-425
18. Guo C, Zeng X, Song J, Zhang M, Wang H, Xu X, Du F, Chen B (2012) A soluble receptor for advanced glycation end-products inhibits hypoxia/reoxygenation-induced apoptosis in rat cardiomyocytes via the mitochondrial pathway. Int J Mol Sci 13(9):11923-11940
19. Xuan YT, Guo Y, Han H, Zhu Y, Bolli R (2001) An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci USA 98(16):9050-9055
20. Aleshin A, Ananthakrishnan R, Li Q, Rosario R, Lu Y, Qu W, Song F, Bakr S, Szabolcs M, D'Agati V, Liu R, Homma S, Schmidt AM, Yan SF, Ramasamy R (2008) RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model. Am J Physiol Heart Circ Physiol 294(4):H1823-1832
21. Pan Z, Sun X, Ren J, Li X, Gao X, Lu C, Zhang Y, Sun H, Wang Y, Wang H, Wang J, Xie L, Lu Y, Yang B (2012) miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models. PLoS ONE 7(11):e50515
22. Shang L, Ananthakrishnan R, Li Q, Quadri N, Abdillahi M, Zhu Z, Qu W, Rosario R, Toure F, Yan SF, Schmidt AM, Ramasamy R (2010) RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways. PLoS ONE 5(4):e10092
23. Song JQ, Teng X, Cai Y, Tang CS, Qi YF (2009) Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion. Apoptosis 14(9):1061-1069
24. Das A, Xi L, Kukreja RC (2005) Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem 280(13):12944-12955
25. Smith CC, Dixon RA, Wynne AM, Theodorou L, Ong SG, Subrayan S, Davidson SM, Hausenloy DJ, Yellon DM (2010) Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore. Am J Physiol Heart Circ Physiol 299(4):H1265-1270
26. Kui L, Weiwei Z, Ling L, Daikun H, Guoming Z, Linuo Z, Renming H (2009) Ghrelin inhibits apoptosis induced by high glucose and sodium palmitate in adult rat cardiomyocytes through the PI3K-Akt signaling pathway. Regul Pept 155(1-3):62-69
27. Toldo S, Seropian IM, Mezzaroma E, Van Tassell BW, Salloum FN, Lewis EC, Voelkel N, Dinarello CA, Abbate A (2011) Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 51(2):244-251
28. Yang J, Marden JJ, Fan C, Sanlioglu S, Weiss RM, Ritchie TC, Davisson RL, Engelhardt JF (2003) Genetic redox preconditioning differentially modulates AP-1 and NF kappa B responses following cardiac ischemia/reperfusion injury and protects against necrosis and apoptosis. Mol Ther 7(3):341-353
29. Yin T, Hou R, Liu S, Lau WB, Wang H, Tao L (2010) Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury. J Mol Cell Cardiol 49(3):354-361
30. Wang K, Zhang J, Liu J, Tian J, Wu Y, Wang X, Quan L, Xu H, Wang W, Liu H (2013) Variations in the protein level of Omi/HtrA2 in the heart of aged rats may contribute to the increased susceptibility of cardiomyocytes to ischemia/reperfusion injury and cell death: Omi/HtrA2 and aged heart injury. Age (Dordr) 35(3):733-746
31. Yang K, Zhang TP, Tian C, Jia LX, Du J, Li HH (2012) Carboxyl terminus of heat shock protein 70-interacting protein inhibits angiotensin II-induced cardiac remodeling. Am J Hypertens 25(9):994-1001
32. Qian W, Xiong X, Fang Z, Lu H, Wang Z (2014) Protective effect of tetramethylpyrazine on myocardial ischemia-reperfusion injury. Evid Based Complement Alternat Med 2014:107501
33. Badalzadeh R, Yousefi B, Majidinia M, Ebrahimi H (2014) Anti-arrhythmic effect of diosgenin in reperfusion-induced myocardial injury in a rat model: activation of nitric oxide system and mitochondrial K channel. J Physiol Sci 64(6):393-400
34. Rosano GM, Fini M, Caminiti G, Barbaro G (2008) Cardiac metabolism in myocardial ischemia. Curr Pharm Des 14(25):2551-2562
35. Fliss H, Gattinger D (1996) Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79(5):949-956
36. Long X, Boluyt MO, Hipolito ML, Lundberg MS, Zheng JS, O'Neill L, Cirielli C, Lakatta EG, Crow MT (1997) p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest 99(11):2635-2643
37. Toth A, Nickson P, Qin LL, Erhardt P (2006) Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase. J Biol Chem 281(6):3679-3689
38. Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C (2002) Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2: Bax ratio. Cancer Res 62(16):4592-4598
39. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281(5381):1309-1312
40. Patel JR, Brewer GJ (2008) Age-related differences in NFkappaB translocation and Bcl-2/Bax ratio caused by TNFalpha and Abeta42 promote survival in middle-age neurons and death in old neurons. Exp Neurol 213(1):93-100
41. Hattori R, Maulik N, Otani H, Zhu L, Cordis G, Engelman RM, Siddiqui MA, Das DK (2001) Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol 33(11):1929-1936
42. Tian Y, Zhang W, Xia D, Modi P, Liang D, Wei M (2011) Postconditioning inhibits myocardial apoptosis during prolonged reperfusion via a JAK2-STAT3-Bcl-2 pathway. J Biomed Sci 18:53
43. Imada K, Leonard WJ (2000) The Jak-STAT pathway. Mol Immunol 37(1-2):1-11
44. Brisslert M, Amu S, Pullerits R (2013) Intra-peritoneal sRAGE treatment induces alterations in cellular distribution of CD19(+), CD3(+) and Mac-1(+) cells in lymphoid organs and peritoneal cavity. Cell Tissue Res 351(1):139-148
45. Hausenloy DJ, Yellon DM (2007) Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 12(3-4):217-234
46. Bucciarelli LG, Ananthakrishnan R, Hwang YC, Kaneko M, Song F, Sell DR, Strauch C, Monnier VM, Yan SF, Schmidt AM, Ramasamy R (2008) RAGE and modulation of ischemic injury in the diabetic myocardium. Diabetes 57(7):1941-1951
47. Goodman MD, Koch SE, Fuller-Bicer GA, Butler KL (2008) Regulating RISK: a role for JAK-STAT signaling in postconditioning? Am J Physiol Heart Circ Physiol 295(4):H1649-1656.